Reddit sentiment leans positive on efficiency and pharmacy reputability
Several states have expanded NP authority in the past three years, and additional legislation is pending in multiple restricted and reduced states in 2026
Due to these findings, Rybelsus' manufacturer plans to request FDA approval in 2023
GLP-1 medicines were first made to help with diabetes and weight loss, but they might also have some benefits for people with Crohns disease, says Raseen Tariq, MD, a gastroenterologist and an assistant professor of medicine in the division of gastroenterology, hepatology, and nutrition at Virginia Commonwealth Universitys school of medicine in Richmond
Manninen S, Silvennoinen S, Bendel P, Lankinen M, Schwab US, Sankilampi U